Metrics to compare | 603998 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603998PeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.9x | 28.7x | −0.3x | |
PEG Ratio | 1.15 | −0.83 | 0.00 | |
Price/Book | 2.6x | 2.7x | 2.6x | |
Price / LTM Sales | 2.6x | 2.8x | 3.1x | |
Upside (Analyst Target) | 60.6% | 32.4% | 47.6% | |
Fair Value Upside | Unlock | 17.2% | 5.6% | Unlock |
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets; Lysine Vitamin B12 granules; Cephalosporin tablets, Jinying capsules; Pudilan anti-inflammatory tablets; Tenghuang Jian Gu tablets; Xiaoer Jingxing Zhike granules; Yizhemaibu tablets; Xuanqi Jian tablets; Xuanqi Jian Gu tablets, Qiangli Pipa Gao, strong loquat syrup, and others. Hunan Fangsheng Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changsha, China.